Class IIOngoingD-0381-2021
Drug recall · May 26, 2021
PremierZen Extreme 3000 recall
Why: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PremierZen Extreme 3000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ
- Lots / codes
all lots
- Quantity
- 500 cards
- Company
- Hyobin LLC, Ridgewood, NJ
- Distribution
- USA Nationwide
- Initiated
- April 6, 2021 · Voluntary: Firm initiated
- Classified
- May 14, 2021
- Reported
- May 26, 2021
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.